Research from AMC Global and OpinionRoute shows GLP-1 users are seeking tailored food products, highlighting opportunities for food & beverage innovation
PRESS RELEASE
AMC Global, an international custom market research firm specializing in launch strategies and brand tracking, and OpinionRoute, a leader in insights process management, have released the second wave of their new study on GLP-1 medication users and food choices. GLP-1 drugs include brand names like Ozempic, Mounjaro, Trulicity, Wegovy and more.
The second wave of the GLP-1 weight loss user study shows that they are looking for products tailored to their unique needs. While many GLP-1 users are seeking whole foods, the insights also show potential for new product development for food and beverage brands offering bars, snack foods, pasta, bread, cereal and even frozen pizza. This growing group of consumers are especially drawn to products that promote functional benefits such as protein, fiber, antioxidants and energy. GLP-1 users are also consuming smaller portions—making it essential to design products that align with their reduced consumption habits.
Click here or on the callout below for a full graphical representation of the data.
Key findings from AMC’s “Impact of GLP-1 on Food Choices” study:
- Seventy-nine percent (79%) of GLP-1 users are extremely or very interested in food and beverage products designed specifically for them.
- Top products GLP-1 users are seeking include yogurt (53%), cheese (50%), red meat (47%), fresh fruit (47%), bars (41%) and salty snacks (39%).
- Fifty-seven percent (57%) are looking for protein-rich foods.
- Other functional benefits GLP-1 users are seeking include fiber (41%), antioxidants (39%), energy (38%), and omega-3s (38%).
“GLP-1 users represent a quickly growing consumer segment that is highly receptive to food and beverage products designed specifically for their unique needs,” said Erin Russeck, Chief Research Officer at AMC Global. “There’s a clear opportunity for brands to innovate with offerings that provide functional benefits this population is seeking.”
A complete representation of the “Food & Beverage Products Sought by GLP-1 Users” can be found here. Data was collected mid-September from n=301 U.S. general population consumers over age 21 with an oversample to n=150 of those who are or have taken GLP-1s for weight loss. The first release of this study can be found here.
The study findings are designed to help clients and industry leaders navigate quickly changing consumer behavior. Contact us to learn more!